Vald�s, Eduardo
October 1964
Angiology;Oct1964, Vol. 15 Issue 10, p431
Academic Journal
Evaluates the action of vasoactive drugs on reabsorption. Acceleration in the reabsorption of sodium; Absence of differences in connection with the intensity of the action of butylsympatol, acetylcholine and Regitine; Influence of the increase in dermal flow on the obliteration of arteriopathies.


Related Articles

  • Can we Develop Neurally Acting Drugs for the Treatment of Migraine? Goadsby, Peter J. // Nature Reviews Drug Discovery;Sep2005, Vol. 4 Issue 9, p741 

    Serotonin (5-HT)1B/1D receptor agonists, which are also known as triptans, represent the most important advance in migraine therapeutics in the four millennia that the condition has been recognized. The vasoconstrictive activity of triptans produced a small clinical penalty in terms of coronary...

  • Enhanced vascular responses to noradrenaline in isolated omental arteries from patients with advanced cirrhosis: evidence against intrinsic vascular hyporeactivity in cirrhosis. Vaughan, R. B.; Angus, P. W.; Angus, J. A. // Gut;Oct2004, Vol. 53 Issue 10, p1544 

    This article reports that the mesenteric and systemic vasodilatation that occurs in advanced liver disease leads to the development of a hyperdynamic circulatory state, which in turn underlies many of the complications of cirrhosis. Studies of isolated vessel preparations from cirrhotic animal...

  • Regulation of sympathetic nerve traffic to skeletal muscle in resting humans. Wallin, B. // Clinical Autonomic Research;Aug2006, Vol. 16 Issue 4, p262 

    An overview is given of microneurographic studies of resting vasoconstrictor traffic in human muscle nerves (muscle sympathetic nerve activity = MSNA). In multiunit recordings, the activity consists of synchronized bursts of vasoconstrictor impulses, the outflow of which is under potent arterial...

  • Comparison of the cerebral effects of dopamine and norepinephrine in severely head-injured patients. Ract, C.; Vigué, B. // Intensive Care Medicine;Jan2001, Vol. 27 Issue 1, p101 

    Objective: To compare the cerebral effects of dopamine and norepinephrine after severe head injury. Design: Prospective, clinical study. Setting: Surgical intensive care unit in a university hospital. Patients: Nineteen patients with severe head-injuries already requiring vasopressor therapy....

  • FDA Drug Approvals: Crestor.  // Formulary;Sep2003, Vol. 38 Issue 9, p509 

    Offers information on the pharmacology of the resuvastatin drug Crestor. Approval for treatment of lipid disorders; Performance of the drug in the treatment of patients with hypercholesterolemia; Contraindication of resuvastatin in liver disease or persistent elevations of serum transaminases.

  • Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects. Mulder, W.M.C.; de Klerk, S.; Settels, J.J.; van Boxtel, C.J. // Clinical Drug Investigation;2002, Vol. 22 Issue 9, p593 

    Objective: To evaluate the cardiovascular effects over time of a single subcutaneous (SC) dose of terbutaline 0.75mg in young healthy volunteers using continuous, beat-to-beat monitoring of cardiovascular effects. Design and methods: Nine healthy young volunteers were administered a SC dose of...

  • Statin Use in Patients with Abnormal Liver Function.  // Internal Medicine Alert;1/15/2011 Clinical Briefs, p1 

    The article offers pharmacology updates focusing on a recent study which shows that statins can improve liver abnormalities in patients with fatty liver.

  • Why a New Journal in Cardiovascular Pharmacology and Therapeutics? Singh, Bramah N. // Journal of Cardiovascular Pharmacology & Therapeutics;Mar1996, Vol. 1 Issue 1, p1 

    The article offers information on the "Journal of Cardiovascular Pharmacology and Therapeutics."

  • Mast Cell Inhibition Attenuates Myocardial Damage, Adverse Remodeling, and Dysfunction During Fulminant Myocarditis in the Rat. Mina, Yair; Rinkevich-Shop, Shunit; Konen, Eli; Goitein, Orly; Kushnir, Tammar; Epstein, Frederick H.; Feinberg, Micha S.; Leor, Jonathan; Landa-Rouben, Natalie // Journal of Cardiovascular Pharmacology & Therapeutics;Mar2013, Vol. 18 Issue 2, p152 

    Background: Myocarditis is a life-threatening heart disease characterized by myocardial inflammation, necrosis, and chronic fibrosis. While mast cell inhibition has been suggested to prevent fibrosis in rat myocarditis, little is known about its effectiveness in attenuating cardiac remodeling...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics